AmerisourceBergen Corpora... (ABC)
NYSE: ABC
· Real-Time Price · USD
179.98
-0.41 (-0.23%)
At close: Aug 29, 2023, 10:00 PM
AmerisourceBergen Revenue Breakdown
| Period Ending | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Distribution Revenue | 51.25B | 49.31B | 47.1B | 50.49B | 47.29B | 43.58B | 45.56B | 46.04B | 43.87B | 43.53B | 41.68B | 43.74B | 41.73B | 41.58B | 39.45B | 38.94B | 38.33B | 37.03B | 35.52B | 36.58B | 36B | 35.37B | 34.17B | 35.19B | 32.76B | 31.76B | 32.98B | 29.81B | 27.93B | 28.62B | 24.09B | 21.49B | 20.13B | 21.08B | 19.09B | 19.37B |
| Pharmaceutical Distribution Revenue Growth | +3.92% | +4.69% | -6.72% | +6.78% | +8.51% | -4.35% | -1.03% | +4.95% | +0.78% | +4.44% | -4.73% | +4.84% | +0.35% | +5.40% | +1.32% | +1.60% | +3.49% | +4.26% | -2.89% | +1.61% | +1.76% | +3.54% | -2.92% | +7.44% | +3.14% | -3.70% | +10.63% | +6.73% | -2.41% | +18.83% | +12.08% | +6.74% | -4.50% | +10.47% | -1.48% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|
| International Healthcare Solutions Revenue | 7.79B | 7.17B | 7.46B | 21.58B | 7.05B |
| International Healthcare Solutions Revenue Growth | +8.60% | -3.81% | -65.44% | +205.96% | n/a |
| U.S. Healthcare Solutions Revenue | 72.88B | 68.28B | 74.03B | 198.15B | 67.19B |
| U.S. Healthcare Solutions Revenue Growth | +6.73% | -7.77% | -62.64% | +194.90% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.67B | 1.6B | 1.47B | 1.56B | 1.38B | 1.4B | 1.39B | 1.3B | 1.32B | 1.29B | 1.26B | 1.21B | 1.2B | 1.17B | 1.22B | 913.41M | 730.08M | 735.07M | 720.97M | 666.88M | 693.41M | 685.95M | 721.94M | 656.94M | 628.04M | 656.59M | 657.8M | 626.55M | 617.43M | 558.52M | 560.88M | 525.46M | 521.84M | 520.55M | 520.15M | 520.03M | 522.76M | 528.3M | 556.37M | 502.74M | 442.44M |
| Selling, General, and Administrative Revenue Growth | +4.55% | +8.69% | -5.90% | +13.10% | -1.11% | +0.35% | +6.88% | -1.28% | +2.34% | +2.17% | +4.23% | +0.74% | +2.83% | -3.75% | +33.09% | +25.11% | -0.68% | +1.96% | +8.11% | -3.83% | +1.09% | -4.99% | +9.89% | +4.60% | -4.35% | -0.19% | +4.99% | +1.48% | +10.55% | -0.42% | +6.74% | +0.69% | +0.25% | +0.08% | +0.02% | -0.52% | -1.05% | -5.05% | +10.67% | +13.63% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |